Several study reported that the tissue levels of ANRIL were higher versus the corresponding adjacent non-tumor tissues, which implied that ANRIL might play an oncogenic role in BC (Hoffmann et al., 2015[20]; Zhu et al., 2015[49]). This evidence concerns the gene CDKN2B-AS1 and neoplasm.